PR PolyResearch

Join Free

NASDAQ

bioAffinity Technologies, Inc. (BIAF)

♥ 411 Thanks from members

bioAffinity Technologies (BIAF) displays extreme divergence between rapid commercial acceleration for its flagship CyPath Lung test and severe financial distress, marked by micro-cap dilution, recurring losses, and a Nasdaq minimum bid price compliance warning.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)